CLINICAL_TRIALS
trial_result
· 2021-11-05
Clinical Trial Update: Rifaximin Therapy in Chronic Kidney Disease [Phase 4]
Summary
Phase 4 clinical trial update on rifaximin therapy in chronic kidney disease; study completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jason Stubbs, MD | Conditions: Chronic Kidney Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-11-05